Raffa Wealth Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PTCT
RI
JT
HRCM
Raffa Wealth Management's PTCT Position: Q2 2026 in Review
Raffa Wealth Management held its PTC Therapeutics (PTCT) position steady in Q2 2026 at 11 shares worth $897. The position accounts for ﹤0.01% of the portfolio, ranked #1052.
Raffa Wealth Management first reported a position in PTCT in Q1 2020 and has held it in 26 quarters since. The position peaked at $900 in Q1 2021. 355 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Raffa Wealth Management held 11 shares of PTC Therapeutics worth $897 as of Q2 2026.
- Raffa Wealth Management left its PTC Therapeutics share count unchanged in Q2 2026.
- PTC Therapeutics made up ﹤0.01% of Raffa Wealth Management's portfolio in Q2 2026, its #1052 holding.
- Raffa Wealth Management first reported a position in PTC Therapeutics in Q1 2020 and has held it in 26 quarters since.
- Raffa Wealth Management's PTC Therapeutics position peaked at $900 in Q1 2021.
- 355 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Raffa Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.